Cargando…
Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the conf...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302309/ https://www.ncbi.nlm.nih.gov/pubmed/35322580 http://dx.doi.org/10.1002/cam4.4644 |
_version_ | 1784751608745164800 |
---|---|
author | Zhang, Xindi Trendowski, Matthew R. Wilkinson, Emma Shahbazi, Mohammad Dinh, Paul C. Shuey, Megan M. Feldman, Darren R. Hamilton, Robert J. Vaughn, David J. Fung, Chunkit Kollmannsberger, Christian Huddart, Robert Martin, Neil E. Sanchez, Victoria A. Frisina, Robert D. Einhorn, Lawrence H. Cox, Nancy J. Travis, Lois B. Dolan, M. Eileen |
author_facet | Zhang, Xindi Trendowski, Matthew R. Wilkinson, Emma Shahbazi, Mohammad Dinh, Paul C. Shuey, Megan M. Feldman, Darren R. Hamilton, Robert J. Vaughn, David J. Fung, Chunkit Kollmannsberger, Christian Huddart, Robert Martin, Neil E. Sanchez, Victoria A. Frisina, Robert D. Einhorn, Lawrence H. Cox, Nancy J. Travis, Lois B. Dolan, M. Eileen |
author_sort | Zhang, Xindi |
collection | PubMed |
description | PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the confounding effect of cranial radiotherapy. METHODS: Utilizing linear and logistic regression analyses on 1680 well‐characterized cisplatin‐treated testicular cancer survivors, we analyzed associations of hearing loss, tinnitus, and peripheral neuropathy with nongenetic comorbidities. Genome‐wide association studies and gene‐based analyses were performed on each phenotype. RESULTS: Hearing loss, tinnitus, and peripheral neuropathy, accounting for age and cisplatin dose, were interdependent. Survivors with these neurotoxicities experienced more hypertension and poorer self‐reported health. In addition, hearing loss was positively associated with BMIs at clinical evaluation and nonwork‐related noise exposure (>5 h/week). Tinnitus was positively associated with tobacco use, hypercholesterolemia, and noise exposure. We observed positive associations between peripheral neuropathy and persistent vertigo, tobacco use, and excess alcohol consumption. Hearing loss and TXNRD1, which plays a key role in redox regulation, showed borderline significance (p = 4.2 × 10(−6)) in gene‐based analysis. rs62283056 in WFS1 previously found to be significantly associated with hearing loss (n = 511), was marginally significant in an independent replication cohort (p = 0.06; n = 606). Gene‐based analyses identified significant associations between tinnitus and WNT8A (p = 2.5 × 10(−6)), encoding a signaling protein important in germ cell tumors. CONCLUSIONS: Genetics variants in TXNRD1 and WNT8A are notable risk factors for hearing loss and tinnitus, respectively. Future studies should investigate these genes and if replicated, identify their potential impact on preventive strategies. |
format | Online Article Text |
id | pubmed-9302309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93023092022-07-22 Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy Zhang, Xindi Trendowski, Matthew R. Wilkinson, Emma Shahbazi, Mohammad Dinh, Paul C. Shuey, Megan M. Feldman, Darren R. Hamilton, Robert J. Vaughn, David J. Fung, Chunkit Kollmannsberger, Christian Huddart, Robert Martin, Neil E. Sanchez, Victoria A. Frisina, Robert D. Einhorn, Lawrence H. Cox, Nancy J. Travis, Lois B. Dolan, M. Eileen Cancer Med RESEARCH ARTICLES PURPOSE: Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without the confounding effect of cranial radiotherapy. METHODS: Utilizing linear and logistic regression analyses on 1680 well‐characterized cisplatin‐treated testicular cancer survivors, we analyzed associations of hearing loss, tinnitus, and peripheral neuropathy with nongenetic comorbidities. Genome‐wide association studies and gene‐based analyses were performed on each phenotype. RESULTS: Hearing loss, tinnitus, and peripheral neuropathy, accounting for age and cisplatin dose, were interdependent. Survivors with these neurotoxicities experienced more hypertension and poorer self‐reported health. In addition, hearing loss was positively associated with BMIs at clinical evaluation and nonwork‐related noise exposure (>5 h/week). Tinnitus was positively associated with tobacco use, hypercholesterolemia, and noise exposure. We observed positive associations between peripheral neuropathy and persistent vertigo, tobacco use, and excess alcohol consumption. Hearing loss and TXNRD1, which plays a key role in redox regulation, showed borderline significance (p = 4.2 × 10(−6)) in gene‐based analysis. rs62283056 in WFS1 previously found to be significantly associated with hearing loss (n = 511), was marginally significant in an independent replication cohort (p = 0.06; n = 606). Gene‐based analyses identified significant associations between tinnitus and WNT8A (p = 2.5 × 10(−6)), encoding a signaling protein important in germ cell tumors. CONCLUSIONS: Genetics variants in TXNRD1 and WNT8A are notable risk factors for hearing loss and tinnitus, respectively. Future studies should investigate these genes and if replicated, identify their potential impact on preventive strategies. John Wiley and Sons Inc. 2022-03-23 /pmc/articles/PMC9302309/ /pubmed/35322580 http://dx.doi.org/10.1002/cam4.4644 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Zhang, Xindi Trendowski, Matthew R. Wilkinson, Emma Shahbazi, Mohammad Dinh, Paul C. Shuey, Megan M. Feldman, Darren R. Hamilton, Robert J. Vaughn, David J. Fung, Chunkit Kollmannsberger, Christian Huddart, Robert Martin, Neil E. Sanchez, Victoria A. Frisina, Robert D. Einhorn, Lawrence H. Cox, Nancy J. Travis, Lois B. Dolan, M. Eileen Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title | Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title_full | Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title_fullStr | Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title_full_unstemmed | Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title_short | Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy |
title_sort | pharmacogenomics of cisplatin‐induced neurotoxicities: hearing loss, tinnitus, and peripheral sensory neuropathy |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302309/ https://www.ncbi.nlm.nih.gov/pubmed/35322580 http://dx.doi.org/10.1002/cam4.4644 |
work_keys_str_mv | AT zhangxindi pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT trendowskimatthewr pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT wilkinsonemma pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT shahbazimohammad pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT dinhpaulc pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT shueymeganm pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT feldmandarrenr pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT hamiltonrobertj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT vaughndavidj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT fungchunkit pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT kollmannsbergerchristian pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT huddartrobert pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT martinneile pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT sanchezvictoriaa pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT frisinarobertd pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT einhornlawrenceh pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT coxnancyj pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT travisloisb pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy AT dolanmeileen pharmacogenomicsofcisplatininducedneurotoxicitieshearinglosstinnitusandperipheralsensoryneuropathy |